New York AG Plies Third Pact Pushing DNA Testing On Supplement Firms
This article was originally published in The Rose Sheet
Executive Summary
NBTY notes that FDA regulations allow firms flexibility in test methodologies for ingredient identity and other testing required under the supplement GMP final rule, and industry stakeholders say compliance with the GMPs is the standard, not a state agency's preferences.
You may also be interested in...
Custom Supplement Firm Shut Down: Health And Wellness Industry News
Warning letter and multiple form 483s fail to convince Custompax; Kellogg acquires RXBAR clean-label protein bars for $600m; NutraFuels used Blast Cap for products; and more news in brief.
CRN Looks Over Medical Food Market Regulation As New Menu Item
The trade group and food and drug attorney Scott Bass note FDA's interpretation of medical food stated in its guidance could undermine congressional intent for the category and limit the range of products firms can market as medical foods.
Supplement Industry Self-Regulation At Center Stage As Oversight Dims Under Trump
The Trump administration's easing of industries' regulatory burdens leaves an oversight void some states are ready to fill, while also giving the supplement industry an opportunity to show self-regulation makes a difference in the quality of products available to US consumers, say food and drug law attorneys.